Cancer News and Research

Latest Cancer News and Research

Four genetic variants in non-small cell lung cancer patients help predict survival, treatment response

Researchers at the Moffitt Cancer Center have identified four inherited genetic variants in non-small cell lung cancer patients that can help predict survival and treatment response. Their findings could help lead to more personalized treatment options and improved outcomes for patients.

9 Aug 2013

Celgene's pomalidomide gets approval in UK for multiple myeloma

Celgene confirmed today that Pomalidomide Celgene▼ (pomalidomide), a new oral blood cancer therapy, has been granted Marketing Authorisation by the European Medicines Agency and is now available in the UK and Ireland.

9 Aug 2013

New microfluidic chip can capture live CTCs from patient's blood

Tumor cells circulating within a patient's bloodstream can carry cancer from a primary tumor site to distant sites of the body, spreading the disease.

9 Aug 2013

Research analysts assess ob-gyn physicians' use of multiple guidelines for breast cancer screening

For breast cancer screening, there are more clinical practice guidelines available to physicians than for any other medical procedure. A new study in the Journal for Healthcare Quality reports that when different clinical guidelines exist, physicians choose recommendations from multiple, sometimes conflicting, sources.

9 Aug 2013

TUM scientists decode typical protein profile of tumor cells

In what is the biggest study of its kind to date, researchers from Technische Universit-t M-nchen have identified over 10,000 different proteins in cancer cells. "Nearly all anti-tumor drugs are targeted against cellular proteins," says Prof. Bernhard K-ster, Head of the TUM Chair of Proteomics and Bioanalytics. "Identifying the proteome the protein portfolio of tumor cells increases our chances of finding new targets for drugs."

9 Aug 2013

Research suggests blocking DNA repair complex helps fight therapy-resistant leukemia

New research posted online by the Nature journal Leukemia suggests blocking part of a DNA repair complex that helps some types of leukemia resist treatment can increase the effectiveness of chemotherapy and enhance survival.

9 Aug 2013

Tobacco-Free Teens app prevents teens from smoking

An app to prevent teens from smoking and encourage them to quit if they've started is now just a few taps away and available free on the Apple iTunes Store.

9 Aug 2013

Study: Immune-regulating molecules can trigger lymphomas

A small group of immune-regulating molecules, when overproduced even moderately, can trigger the blood cancers known as lymphomas, according to a new study led by scientists from The Scripps Research Institute (TSRI).

9 Aug 2013

Journey Forward creates tool to help cancer survivors initiate care planning with health care providers

Journey Forward, a leader in Survivorship Care Planning, is moving forward patient-centered care by enhancing its suite of free, award-winning survivorship care planning tools with My Care Plan.

9 Aug 2013

Eisai's investigational compound receives orphan drug designation for cutaneous t-cell lymphoma

Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.

9 Aug 2013

New reagent kits for intracellular staining from Beckman Coulter Life Sciences

PerFix-Expose1 and PerFix-nc1, innovative new reagent kits for intracellular staining from Beckman Coulter Life Sciences, minimize sample manipulation for a streamlined workflow that delivers high quality results. Developed for use on Beckman Coulter’s Gallios1 and Navios2 series flow cytometers and compatible with all Beckman Coulter Life Sciences’ fluorochromes, the kits enable a clear focus on the cytoplasmic and nuclear compartments of the cell.

8 Aug 2013

High mobility group (HMG) genes and cancer: an interview with Dr. Linda Resar, Johns Hopkins University School of Medicine

High mobility group A genes are highly expressed in all aggressive cancers studied to date. These genes encode the high mobility group A (HMGA) proteins. In other words, these genes provide the genetic “code” necessary to produce HMGA proteins.

8 Aug 2013

TruClinic signs new partnership with University of Utah Hospital's Department of Telemedicine

Today TruClinic announced a new partnership with University of Utah Hospital's Department of Telemedicine, which will enable patients and practitioners to have video-based online visits and consultations with simply a computing device, Internet connection and a webcam.

8 Aug 2013

KU researchers receives grant to create new program to help American Indian students stop smoking

The University of Kansas Cancer Center's Cancer Control and Population Health program got a boost in April when Won Choi, Ph.D., and his colleagues were awarded a $2.7 million, five-year NCI grant to create an Internet-based program to help American Indian tribal college students stop smoking.

8 Aug 2013

Findings could lead to development of therapeutic agents for age-related diseases

Scientists at Sanford-Burnham Medical Research Institute have identified a key factor that regulates the autophagy process, a kind of cleansing mechanism for cells in which waste material and cellular debris is gobbled up to protect cells from damage, and in turn, modulates aging.

8 Aug 2013

Penn State researchers find that protein changes can control gene functions

A Penn State-led research team has found that changes to proteins called histones, which are associated with DNA, can control whether or not a gene is allowed to function. The changes may be important in maintaining the genes' "expression potential" so that future cells behave as their parent cells did.

8 Aug 2013

Novartis earns global CEO Cancer Gold Standard accreditation

Novartis International AG, a multinational healthcare company headquartered in Basel, Switzerland, is the first company to earn global CEO Cancer Gold Standard accreditation. Their commitment to workplace wellness reaches across the globe to positively affect the lives of all their employees.

8 Aug 2013

Researchers unveil comprehensive portrait of the genome of world's first immortal cell line

A team from the University of Washington has unveiled a comprehensive portrait of the genome of the world's first immortal cell line, known as HeLa. The cell line was derived in 1951 from an aggressive cervical cancer that killed Henrietta Lacks, a 31-year-old African-American tobacco farmer and mother of five - the subject of the 2010 New York Times bestseller, The Immortal Life of Henrietta Lacks.

8 Aug 2013

One-third of patients with heart pumps develop infection at abdominal power connection site

Cardiac surgeons and cardiologists at the University of Maryland Heart Center are part of a multi-center clinical trial evaluating the efficacy of powering heart pumps through a skull-based connector behind the ear. Typically, these devices for patients with severe heart failure are energized through an electrical cord connected at an abdominal site, where potentially deadly infections can develop.

8 Aug 2013

Ret enzyme may be a novel therapeutic target in selected groups of breast cancer patients

Scientists at the MedUni Vienna, in collaboration with a working group led by Nancy Hynes at the University of Basel, have discovered a new approach in the treatment of breast cancer: an international team involving the Clinical Institute of Pathology at the MedUni Vienna has been able to demonstrate the activation of a receptor, the Ret protein (Rearranged during transfection), on the surface of breast cancer cells. Increased levels of this protein are associated with a lower likelihood of survival for breast cancer patients.

8 Aug 2013

Cancer News and Research

Latest Cancer News and Research

Four genetic variants in non-small cell lung cancer patients help predict survival, treatment response

Celgene's pomalidomide gets approval in UK for multiple myeloma

New microfluidic chip can capture live CTCs from patient's blood

Research analysts assess ob-gyn physicians' use of multiple guidelines for breast cancer screening

TUM scientists decode typical protein profile of tumor cells

Research suggests blocking DNA repair complex helps fight therapy-resistant leukemia

Tobacco-Free Teens app prevents teens from smoking

Study: Immune-regulating molecules can trigger lymphomas

Journey Forward creates tool to help cancer survivors initiate care planning with health care providers

Eisai's investigational compound receives orphan drug designation for cutaneous t-cell lymphoma

New reagent kits for intracellular staining from Beckman Coulter Life Sciences

High mobility group (HMG) genes and cancer: an interview with Dr. Linda Resar, Johns Hopkins University School of Medicine

TruClinic signs new partnership with University of Utah Hospital's Department of Telemedicine

KU researchers receives grant to create new program to help American Indian students stop smoking

Findings could lead to development of therapeutic agents for age-related diseases

Penn State researchers find that protein changes can control gene functions

Novartis earns global CEO Cancer Gold Standard accreditation

Researchers unveil comprehensive portrait of the genome of world's first immortal cell line

One-third of patients with heart pumps develop infection at abdominal power connection site

Ret enzyme may be a novel therapeutic target in selected groups of breast cancer patients

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in